[ Price : $8.95]
FDA grants Wave Life Sciences a rare pediatric disease designation for WVE-N531 and its use in treating boys with Duchenne muscula...[ Price : $8.95]
FDA approves a Vericel supplemental BLA for NexoBrid (anacaulase-bcdb) for eschar removal in pediatric patients with deep partial-...[ Price : $8.95]
Two stakeholders respond to an FDA request for comments on the agencys recent listening session on advisory committees and their g...[ Price : $8.95]
Gardner Law says prescription drug manufacturers and marketers need to be sure their social media promotions can withstand FDA scr...[ Price : $8.95]
FDA gives accelerated approval to Gileads Livdelzi to treat some cases of primary biliary cholangitis.[ Price : $8.95]
After reporting preliminary positive results from a Phase 2 clinical trial studying VP-315 in basal cell carcinoma patients, Verri...[ Price : $8.95]
FDA approves Incytes Niktimvo for some adult and pediatric host-versus-graft treatments.